Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Awasthi M, Golding H, Khurana S. SARS-CoV-2 hyperimmune intravenous human immunoglobulins neutralizes Omicron subvariants BA.1, BA.2, BA.2.12.1, BA.3 and BA.4/BA.5 for treatment of COVID-19. Clin Infect Dis 2022 Aug 4. pii: 6655744. doi: 10.1093.
PMID: 35925647


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016